EUTECNIQAtlas

Every page of EUTECNIQ on one mapArrow keys move through results · Enter opens · Esc closes

Supplements A–Z · by effect 18 graded findings

Urinary tract and prostate

What human research has studied for urinary tract infection and prostate symptoms, across every ingredient in this guide, strongest evidence first. A grade describes the evidence, not a recommendation.

Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. Ask a doctor or pharmacist before use, especially with medicines, in pregnancy or for a child.

Summary

How strong the evidence is

Show

Where urinary tract and prostate sits on the supplement body map; colored by its strongest grade here.

Findings

Findings by ingredient

Urinary tract and prostate: findings by ingredient and grade
IngredientGradeWhat was studied and found
CranberryAUTI after a medical intervention. Cochrane 2023: 6 trials, 1,434 people susceptible to UTI after an intervention; RR 0.47 (95% CI 0.37 to 0.61; I² = 0%). sources
CranberryBRecurrent urinary tract infections in women. Cochrane 2023: 8 trials, 1,555 participants; symptomatic, culture-verified UTI RR 0.74 (95% CI 0.55 to 0.99), with moderate heterogeneity (I² = 54%). NCCIH describes findings as inconsistent. sources
CranberryBUrinary tract infections in children. Cochrane 2023: 5 trials, 504 participants; RR 0.46 (95% CI 0.32 to 0.68). sources
Stinging nettleBRoot extract trials in men with benign prostatic hyperplasia. LiverTox summarizes a 52-week trial (226 men, 429 mg root extract) with slightly larger symptom-score gains than placebo (-5.7 vs -4.8) and a 558-man crossover trial reporting 81% vs 16% improvement. sources
BPC-157CInterstitial cystitis (injection into the bladder wall). A single-arm pilot study in 12 women (10 mg injected during cystoscopy) reported complete symptom resolution in 10 and 80% improvement in 2; there was no comparison group. sources
CranberryCNeuromuscular bladder dysfunction. Cochrane 2023: 3 trials, 464 adults with incomplete bladder emptying; RR 0.97 (95% CI 0.78 to 1.19), low-certainty evidence. sources
FucoidanCUrinary symptoms in benign prostatic hyperplasia. RCT in 95 men aged 45–80 with moderate BPH: Undaria pinnatifida fucoidan for 90 days reduced symptom scores (IPSS −3.40 vs −0.93 with placebo); urine flow, residual volume and PSA did not differ. sources
Pumpkin seedCUrinary symptoms from benign prostatic enlargement. In a 12-month, partially blinded RCT of 1,431 men aged 50–80, response with pumpkin seed (5 g twice daily) was 58.5% versus 47.3% with placebo (descriptively significant); seed-extract capsules did not differ from placebo. sources
Pumpkin seedCProstate symptoms: seed oil versus tamsulosin. In a 3-month single-blind trial of 73 men, symptom scores improved with pumpkin seed oil (360 mg twice daily) and with tamsulosin, but fell more with tamsulosin by months 1 and 3. sources
Pumpkin seedCOveractive bladder in women (combination product). An uncontrolled, industry-funded 12-week observational study of a pumpkin seed oil, Rhus aromatica and hop combination in 117 women reported fewer daytime and nighttime urinations. sources
ReishiCLower urinary tract symptoms in men. One dose-ranging RCT in 50 men aged 50 and older: an extract (0.6, 6 or 60 mg once daily) improved symptom scores (IPSS) versus placebo; urine flow, prostate volume and PSA did not change. sources
Rose hipCUrinary tract infection after cesarean delivery. In one RCT of 400 women, 500 mg Rosa canina fruit capsules twice daily for 20 days were followed by fewer positive urine cultures than placebo; cystitis incidence did not differ. sources
Saw palmettoCChronic prostatitis/chronic pelvic pain syndrome. A 2022 review of five studies did not find a significant benefit. sources
Stinging nettleCRoot: lower urinary tract symptoms of benign prostatic hyperplasia (regulatory assessment). EMA's herbal committee (2025) found eight randomized, double-blind, placebo-controlled root trials but judged them inadequate to prove efficacy: short, small, poorly defined preparations. It accepted traditional use only. sources
CranberryXElderly people in long-term care. Cochrane 2023: 3 trials, 1,489 participants; RR 0.93 (95% CI 0.67 to 1.30), moderate-certainty evidence of no clear benefit. sources
CranberryXPregnant women. Cochrane 2023: 3 trials, 765 participants; RR 1.06 (95% CI 0.75 to 1.50), moderate-certainty evidence of no clear benefit. sources
Saw palmettoXUrinary symptoms of benign prostatic enlargement (BPH). Cochrane (2023): 27 studies, 4,656 participants; saw palmetto alone made little to no difference in symptoms or quality of life at 3 to 6 and 12 to 17 months (high-certainty evidence). sources
Saw palmettoXHexane-extracted versus other products for BPH. Reviewers analyzed hexane-extracted products separately and found no difference in effect on BPH symptoms. sources
A
Consistent results from several randomized trials or a systematic review of them
B
Some positive randomized trials, but small, short, few or inconsistent
C
Limited human evidence: single small trials, observational data or mixed results
D
Laboratory or animal evidence only; not shown in people
X
Well-designed human trials found no meaningful effect

All effect categories · All entries A–Z · Interactions

Health information notice

These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.

Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.

EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.

Ready to check what you take?

Free tools built on published reference values, each with its sources and its limits. Your lists stay in your browser.